Caris Life Sciences,�Inc. (CAI) vs Krystal Biotech, Inc. (KRYS)
- Caris Life Sciences,�Inc. CAI 30.56 −3.78%
- Krystal Biotech, Inc. KRYS 316.58 −4.07%
Caris Life Sciences,�Inc. and Krystal Biotech, Inc. are both Biotechnology companies. Caris Life Sciences,�Inc. and Krystal Biotech, Inc. are of similar size ($9.8B and $9.0B). Krystal Biotech, Inc. trades at the lower P/E: 38.3× against 81.3×. Caris Life Sciences,�Inc. grew revenue faster over the last twelve months: 96.4% against 22.6%. Krystal Biotech, Inc. has the higher net margin (54.8% vs 8.15%) and the lower return on invested capital (24.1% vs 50.0%). Across the 20 metrics below, Krystal Biotech, Inc. leads on 15 and Caris Life Sciences,�Inc. on 5.
Valuation
Profitability
| Metric | CAI | KRYS | Biotechnology median |
|---|---|---|---|
| Gross margin | 69.66% | 94.64% | 65.16% |
| Operating margin | 15.49% | 44.89% | 0.00% |
| Net margin | 8.15% | 54.82% | 0.00% |
| Free cash flow margin | 12.53% | 58.52% | 0.00% |
| Return on equity | 15.45% | 20.12% | (56.36%) |
| Return on assets | 7.39% | 18.30% | (48.04%) |
| Return on invested capital | 49.95% | 24.07% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack